1-nitrohydroxyphenyl-n-benzoylalanine has been researched along with Carcinoma, Epidermoid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Benihoud, K; Brenner, C; Breuskin, I; Busson, P; Daste, A; David, M; Durand, S; Even, C; Fayette, J; Garic, F; Gelin, A; Gorphe, P; Le Tourneau, C; Niki, T; Texier, M; Toullec, C; Tran, BT | 1 |
| Beghini, M; Bibiano Borges, CR; de Araújo, MS; de Lima, LM; Miranda Alves, P; Muniz, JM; Napimoga, MH; Nogueira, RD; Pereira, SA; Rodrigues, DB; Rodrigues, V | 1 |
| Hu, Y; Li, J; Li, P; Li, Y; Liu, H; Wan, G; Wang, Z; Ye, J; Zhang, G | 1 |
3 other study(ies) available for 1-nitrohydroxyphenyl-n-benzoylalanine and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Plasma galectins and metabolites in advanced head and neck carcinomas: evidence of distinct immune characteristics linked to hypopharyngeal tumors.
Topics: Carcinoma, Squamous Cell; Galectins; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Papillomavirus Infections; Prospective Studies; Squamous Cell Carcinoma of Head and Neck | 2023 |
Galectin-9 as an important marker in the differential diagnosis between oral squamous cell carcinoma, oral leukoplakia and oral lichen planus.
Topics: Benzamides; Biomarkers, Tumor; Carcinoma, Squamous Cell; Diagnosis, Differential; Galectin 3; Galectins; Humans; Immunohistochemistry; Leukoplakia; Lichen Planus; Mast Cells; Matrix Metalloproteinase 3; Mouth Neoplasms; Tyrosine | 2015 |
The clinical implication of tumoral Gal-1 expression in laryngeal squamous cell carcinomas.
Topics: Adult; Aged; Aged, 80 and over; Benzamides; Carcinoma, Squamous Cell; Female; Humans; Immunohistochemistry; Laryngeal Neoplasms; Male; Middle Aged; Prognosis; Retrospective Studies; Tyrosine | 2013 |